- Home
- PTGX vs SBRA Comparison
PTGX vs SBRA Comparison
Compare PTGX & SBRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- SBRA
- Stock Information
- Founded
- PTGX 2006
- SBRA 2010
- Country
- PTGX United States
- SBRA United States
- Employees
- PTGX N/A
- SBRA N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- SBRA Real Estate Investment Trusts
- Sector
- PTGX Health Care
- SBRA Real Estate
- Exchange
- PTGX Nasdaq
- SBRA Nasdaq
- Market Cap
- PTGX 5.0B
- SBRA 4.3B
- IPO Year
- PTGX 2016
- SBRA N/A
- Fundamental
- Price
- PTGX $86.22
- SBRA $18.74
- Analyst Decision
- PTGX Strong Buy
- SBRA Hold
- Analyst Count
- PTGX 9
- SBRA 9
- Target Price
- PTGX $86.44
- SBRA $20.44
- AVG Volume (30 Days)
- PTGX 914.5K
- SBRA 3.2M
- Earning Date
- PTGX 11-06-2025
- SBRA 11-05-2025
- Dividend Yield
- PTGX N/A
- SBRA 6.40%
- EPS Growth
- PTGX N/A
- SBRA 78.50
- EPS
- PTGX 0.72
- SBRA 0.73
- Revenue
- PTGX $209,217,000.00
- SBRA $747,056,000.00
- Revenue This Year
- PTGX N/A
- SBRA $7.75
- Revenue Next Year
- PTGX $140.23
- SBRA $9.04
- P/E Ratio
- PTGX $118.58
- SBRA $25.74
- Revenue Growth
- PTGX N/A
- SBRA 9.34
- 52 Week Low
- PTGX $33.70
- SBRA $15.60
- 52 Week High
- PTGX $93.25
- SBRA $19.97
- Technical
- Relative Strength Index (RSI)
- PTGX 66.35
- SBRA 55.85
- Support Level
- PTGX $82.06
- SBRA $18.30
- Resistance Level
- PTGX $86.95
- SBRA $18.90
- Average True Range (ATR)
- PTGX 3.03
- SBRA 0.51
- MACD
- PTGX -0.04
- SBRA 0.02
- Stochastic Oscillator
- PTGX 92.09
- SBRA 69.13
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About SBRA Sabra Health Care REIT Inc.
Sabra Health Care REIT Inc is a healthcare facility real estate investment trust. The company operates one segment that owns and invests in healthcare real estate. All of the company's revenue is generated in the United States. Sabra's operations consist of nursing facilities, assisted living centers, and mental health facilities.